Zoll X Series monitor/defibrillator cleared for EMS market

The FDA has given the 510(k) nod to Zoll’s monitor/defibrillator designed for emergency medical services, the X Series.

The model line combines defibrillation, pacing and CPR assistance with advanced monitoring parameters. According to the company, the EMS monitor/defibrillator is able to communicate via Bluetooth, wi-fi or USB cellular modem. It integrates with Zoll’s RescueNet resuscitation-management software.

Publicly traded Zoll is headquartered in Chelmsford, Mass.
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.